Healthcare training firm lands major Dubai deal

Sarah Phillips
X The Business Desk

Register for free to receive latest news stories direct to your inbox


A Nottingham business which helps healthcare professionals improve their skills in venepuncture and cannulation has secured a major deal with Dubai-based Leader Healthcare.

VeinTrain has agreed the deal with the global distribution network which will see its flatpack VeinTrainer supplied to universities and hospitals in UAE, Bahrain and Kuwait.

It follows similar agreements in South Africa and Nigeria in early 2020 benefitting from the training aid and thanks to its simple design and online learning curriculum that can be rapidly deployed across continents like Africa.

With the VeinTrain system now gaining a foothold on two continents outside of Europe, founder Sarah Phillips, who is an author and leader in the field with over 20 years of expertise, hopes to see further take up back on home soil in the UK.

“It is great that we are expanding into new territories and I am very proud of that,” said Phillips.

She added: “It is the next step in the growth of VeinTrain. We have been very busy setting these partnerships up overseas but we are also seeing renewed demand here in the UK given the times we are in around training which can aid in the antibody screening process for Covid19.

“We worked with Guy’s and St Thomas’ NHS Foundation Trust and a wide range of other healthcare providers here in the UK but training right now can be tricky, as physical distancing is a challenge. With our flatpack VeinTrain unit backed by online training resources we can help circumvent that issue and ensure as many healthcare professionals as possible are trained to the highest standards.”

Phillips says she expects to see “huge” reductions in failure rates and complications. The competency programme she led has already reached 75,000 clinicians across the UK, which they estimate is improving 14.5 million patient outcomes per year.

The potential savings have recently been calculated at over £20m per year for one group of hospitals with improved technique compared to current failure rates.